This proposal is predicated on the hypothesis first proposed by B. Pierce that """"""""a determined stem cell required for tissue renewal is the cell of origin for carcinomas (3)."""""""" We propose that the development of new, improved preclinical mouse models for breast cancer may depend on the ability to target specific genetic events to stem/progenitor cells, and that this approach may overcome some of the key limitations of currently available mouse models of breast cancer. Furthermore, improved mouse and human models for studying the early steps in the progression of premalignant disease are required. The proposal is based upon several novel observations made during the previous funding period: 1) the role of p53 in hormone-dependent mammary gland progression, 2) the role of altered p53 in senescence, 3) the generation of a mouse Li-Fraumeni model carrying a gain-of-function p53 mutation, 4) the identification of stem/progenitor cell markers in the mammary gland and existing mouse breast cancer models 5) the development of methods to conditionally, and in some cases reversibly activate oncogenes, or delete tumor suppressor genes. The group of ten co-investigators from four institutions provides the necessary and complementary expertise required to generate and characterize the proposed new mouse models of cancer. The following specific aims are proposed: 1) To generate new mouse models capable of inducibly expressing molecules in Bcrp1+ mammary side-population (SP) cells, and to determine the impact of oncogenic signaling pathways on SP ceils, and the requirement of these cells for mammary tumorigenesis. 2) To develop an inducible mouse model to functionally assess oncogenesis in mammary gland Sca-1+ progenitor cells by a knock-in of the reverse tetracycline-responsive transactivator (rtTA) and the avian leukosis virus TVA receptor into the Sca-1 locus. 3) To identify cell lineage markers for stem and progenitor cells in both the normal mammary gland and the p53 null Balb/c model of breast cancer progression in order to understand the role of stem cells in breast cancer progression and in the etiology of hormone-dependent and independent breast cancer. To understand the role of p53 in mammary stem cell renewal and senescence. 4) To develop a human xenograft model from unfolded Iobules to study early breast cancer progression for comparison with the progression models in the mouse.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA084243-10
Application #
7485131
Study Section
Special Emphasis Panel (ZCA1-SRRB-U (J1))
Program Officer
Marks, Cheryl L
Project Start
1999-09-30
Project End
2010-03-31
Budget Start
2008-04-01
Budget End
2010-03-31
Support Year
10
Fiscal Year
2008
Total Cost
$831,781
Indirect Cost
Name
Baylor College of Medicine
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Kittrell, Frances S; Carletti, Martha Z; Kerbawy, Sofia et al. (2011) Prospective isolation and characterization of committed and multipotent progenitors from immortalized mouse mammary epithelial cells with morphogenic potential. Breast Cancer Res 13:R41
Bu, W; Chen, J; Morrison, G D et al. (2011) Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer. Oncogene 30:4399-409
Illa-Bochaca, Irineu; Fernandez-Gonzalez, Rodrigo; Shelton, Dawne N et al. (2010) Limiting-dilution transplantation assays in mammary stem cell studies. Methods Mol Biol 621:29-47
Zhang, Mei; Atkinson, Rachel L; Rosen, Jeffrey M (2010) Selective targeting of radiation-resistant tumor-initiating cells. Proc Natl Acad Sci U S A 107:3522-7
Fernandez-Gonzalez, Rodrigo; Illa-Bochaca, Irineu; Shelton, Dawne N et al. (2010) In situ analysis of cell populations: long-term label-retaining cells. Methods Mol Biol 621:1-28
Shelton, Dawne N; Fernandez-Gonzalez, Rodrigo; Illa-Bochaca, Irineu et al. (2010) Use of stem cell markers in dissociated mammary populations. Methods Mol Biol 621:49-55
Abba, Martín C; Hu, Yuhui; Levy, Carla C et al. (2009) Identification of modulated genes by three classes of chemopreventive agents at preneoplastic stages in a p53-null mouse mammary tumor model. Cancer Prev Res (Phila) 2:175-84
Welm, Bryan E; Dijkgraaf, Gerrit J P; Bledau, Anita S et al. (2008) Lentiviral transduction of mammary stem cells for analysis of gene function during development and cancer. Cell Stem Cell 2:90-102
Zhang, Mei; Behbod, Fariba; Atkinson, Rachel L et al. (2008) Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res 68:4674-82
Yadav, Neelu; Cheng, Donghang; Richard, Stephane et al. (2008) CARM1 promotes adipocyte differentiation by coactivating PPARgamma. EMBO Rep 9:193-8

Showing the most recent 10 out of 29 publications